MedDataX Logo

Infections in Pediatric Cancer Patients

NCT ID: NCT00930267

Last Updated: 2009-06-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Study Classification

OBSERVATIONAL

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A prospective epidemiological study conducted in pediatric hematology oncology center in Hadassah medical center. The study will include all newly diagnosed pediatric cancer patients age 0-18 years admitted with fever during chemotherapy.

In each event of febrile episode during chemotherapy, the following data will be collected using a patient data form and computerized software.

Demographic data: age, gender, ethnicity. Clinical data: Underlying disease, immunizations, prophylactic antibiotics, presence of central venous catheter, intensity of chemotherapy, duration of fever, duration and severity of neutropenia, diagnosis of present event.

Imaging data Microbiological data Outcome The statistical analysis will be performed by an epidemiologist and statistician using the SPSS 12.0 software.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infections

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

fever children cancer leukemia stem cell transplantation infections in pediatric cancer patients presenting with fever during or following chemotherapy.

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pediatric cancer patients age 0-18 years admitted with fever during or following chemotherapy

Exclusion Criteria

* No exclusions
Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hadassah Medical Organization

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dan Engelhard, MD

Role: PRINCIPAL_INVESTIGATOR

Hadassah Medical Organization

Diana Averbuch, MD

Role: PRINCIPAL_INVESTIGATOR

Hadassah Medical Organization

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Arik Tzukert, DMD

Role: CONTACT

Phone: 00 972 2 6776095

Email: [email protected]

Hadas Lemberg, PhD

Role: CONTACT

Phone: 00 972 2 6777572

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

yael12-HMO-CTIL

Identifier Type: -

Identifier Source: org_study_id